Medicinal Chemistry Research

, Volume 27, Issue 6, pp 1589–1598 | Cite as

Spectroscopic investigation on the interaction characteristics and inhibitory activities between baicalin and acetylcholinesterase

Original Research
  • 49 Downloads

Abstract

Restoring neurotransmitter acetylcholine (ACh) levels by inhibiting acetylcholinesterase (AChE) has become the primary treatment for the cognitive deficits of Alzheimer’s disease. The inhibitory effects of flavonoids on AChE have attracted great interest among researchers, but few reports have focused on the interaction characteristics of inhibitor with AChE. In this work, the interaction of inhibitor baicalin with AChE was studied for the first time by fluorescence spectroscopy coupled with UV spectroscopy and circular dichroism (CD) techniques under near physiological conditions. The fluorescence quenching rate constants and binding constants for baicalin‒AChE system were determined at different temperatures. The fluorescence quenching of AChE by baicalin is due to static quenching and energy transfer. The distance and the binding constant (Ka) between baicalin and AChE were estimated to be 2.85 nm and 9.772 × 104 L mol−1 at 298 K. The results of thermodynamic parameters, ΔH (−174.6 kJ mol−1), ΔS (−489.9 J mol−1 K−1) and ΔG (−28.61 ~ −23.71 kJ mol−1), indicated that van der Waals interaction and hydrogen bonding played a major role for baicalin‒AChE association. Synchronous fluorescence spectral change of AChE showed the binding sites mainly are focused on tryptophan moiety. Circular dichroism spectra showed that baicalin caused a secondary structure change of AChE. Synchronous fluorescence and three-dimensional fluorescence studies showed that the presence of baicalin could change the conformation of AChE during the binding process. Baicalin showed an obvious inhibitory activity, with 1.24 × 10−4 mol L−1 for 50% inhibition of AChE activity (IC50). The in intro studies suggest that the baicalin could decrease catalytic activity of AChE, it is helpful for restoring and rebalancing neurotransmitter ACh levels.

Keywords

Fluorescence Baicalin Acetylcholinesterase Interaction characteristics Inhibitory activities 

Notes

Acknowledgements

This work was supported by the Science Foundation Office of Hebei Province, China (B2014201171).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Akao T, Hanada M, Sakashita Y, Sato K, Morita M, Imanaka T (2007) Efflux of baicalin, a flavone glucuronide of Scutellariae Radix, on Caco-2 cells through multidrug resistance-associated protein. J Pharm Pharmacol 59:87–93CrossRefPubMedGoogle Scholar
  2. Anand P, Singh B (2013) A review on cholinesterase inhibitors for Alzheimer's disease. Arch Pharm Res 36(4):375–399CrossRefPubMedGoogle Scholar
  3. Barbero N, Barni E, Barolo C, Quagliotto P, Viscardi G, Napione L, Pavan S, Bussolino F (2009) A study of the interaction between fluorescein sodium salt and bovine serum albumin by steady-state fluorescence. Dyes Pigments 80:307–313CrossRefGoogle Scholar
  4. Besley NA, Hirst JD (1999) Theoretical studies toward quantitative protein circular dichroism calculations. J Am Chem Soc 121:9636–9644CrossRefGoogle Scholar
  5. Bhattar SL, Kolekar GB, Patil SR (2008) Fluorescence resonance energy transfer between perylene and riboflavin in micellar solution and analytical application on determination of vitamin B2. J Lumin 128(3):306–310CrossRefGoogle Scholar
  6. Bi S, Ding L, Tian Y, Song D, Zhou X, Liu X, Zhang HQ (2004) Investigation of the interaction between flavonoids and human serum albumin. J Mol Struct 703(1–3):37–45CrossRefGoogle Scholar
  7. Castro A, Martinez A (2001) Peripheral and dual binding site acetylcholinesterase inhibitors: implications in treatment of Alzheimer's disease. Mini-Rev Med Chem 1:267–272CrossRefPubMedGoogle Scholar
  8. Chen L, Fang L, Fang X, Gou S (2010) The new target of acetylcholinesterase inhibitors against Alzheimer′s disease research progress. Chin Pharm J 45:1606–1611Google Scholar
  9. Čolović MB, Krstić DZ, Lazarević-Pašti TD, Tamara D, Bondzic AM, Vasic VM (2013) Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol 11:315–335CrossRefPubMedPubMedCentralGoogle Scholar
  10. Ding F, Zhao GY, Huang JL, Sun Y, Zhang L (2009) Fluorescence spectroscopic investigation of the interaction between chloramphenicol and lysozyme. Med Chem 44:4083–4089Google Scholar
  11. Dvir H, Silman I, Harel M, Rosenberry TL, Sussman JL (2010) Acetylcholinesterase: from 3D structure to function. Chem Biol Interact 187:10–22CrossRefPubMedPubMedCentralGoogle Scholar
  12. Ellman GL, Courtney KD, Andres Jr V, Featherstone RM (1961) Biochem Pharmacol 7:88–95CrossRefPubMedGoogle Scholar
  13. Goedert M, Spillantini MG (2006) A century of Alzheimer’s disease. Science 314:777–781CrossRefPubMedGoogle Scholar
  14. Guo M, Lu WJ, Li MH, Wang W (2008) Study on the binding interaction between carnitine optical isomer and bovine serum albumin. Eur J Med Chem 43:2140–2148CrossRefPubMedGoogle Scholar
  15. Guo Y, Sun M, Xing Z, Liu Y (1988) Circular dichroism analysis of acetylcholinesterase Acta Biophysica. Sinica 4:211–214Google Scholar
  16. Guo XJ, Sun XD, Xu SK (2009) Spectroscopic investigation of the interaction between riboflavin and bovine serum albumin. J Mol Struct 931:55–59CrossRefGoogle Scholar
  17. He X, Carter DC (1992) Atomic structure and chemistry of human serum albumin. Nature 358:209–215CrossRefPubMedGoogle Scholar
  18. Hu YJ, Liu Y, Shen XS, Fang XY, Qu SS (2005) Studies on the interaction between 1-hexylcarbamoyl-5-fluorouracil and bovine serum albumin. J Mol Struct 738:143–147CrossRefGoogle Scholar
  19. Hu YJ, Liu Y, Zhao RM, Dong JX, Qu SS (2006) Spectroscopic studies on the interaction between methylene blue and bovine serum albumin. J Photochem Photobiol A 179:324–329CrossRefGoogle Scholar
  20. Khan I, Muhammad N, Nematullah K, Muhammad S, Said N, Farooq A, Nasiara K, Waqar Ahmad K, Mughal Q, Hanif A, Ihsan Ali K (2010) Structural insights to investigate Conypododiol as a dual cholinesterase inhibitor from Asparagus adscendens. Fitoterapia 81:1020–1025CrossRefPubMedGoogle Scholar
  21. Lackowcz JR (2006) Principles of Fluorescence Spectroscopy, 3rd edn. Plenum Press, New York, pp 277–350CrossRefGoogle Scholar
  22. Lin CC, Shieh DE (1996) The anti-inflammatory activity of Scutellaria rivularis extracts and its active components, baicalin, baicalein and wogonin. Am J Chin Med 24(1):31–36CrossRefPubMedGoogle Scholar
  23. Lackowicz JR, Weber G (1973) Quenching of protein fluorescence by oxygen: probe for structural fluctuations in macromolecules. Biochem 12:4161–4170CrossRefGoogle Scholar
  24. Laurents DV, Baldwin RL (1997) Characterization of the unfolding pathway of hen egg white Lysozyme. Biochem 36:1496–1504CrossRefGoogle Scholar
  25. Liu X, Chen X, Xiao J, Zhao J (2010) Effect of hydrogenation on ring C of flavonols on their affinity for bovine serum albumin. J Solut Chem 39:533–542CrossRefGoogle Scholar
  26. Mallick A, Haldar B, Chattopadhyay N (2005) Spectroscopic investigation on the interaction of ICT probe 3-A. quinolizine with serum albumin. J Phys Chem B 109:14683–14690CrossRefPubMedGoogle Scholar
  27. Maurice RE, Camillo AG (1981) Fluorescence quenching studies with proteins. Anal Biochem 114:199–212CrossRefGoogle Scholar
  28. Mukherjee PK, Kumar V, Mal M, Houghton PJ (2007) Acetylcholinesterase inhibitors from plants. Phytomedicine 14:289–300CrossRefPubMedGoogle Scholar
  29. Pohanka M (2012) Acetylcholinesterase inhibitors: a patent review (2008–present). Expert Opin Ther Pat 22:871–886CrossRefPubMedGoogle Scholar
  30. Ross PD, Subramanian S (1981) Thermodynamics of protein association reactions: forces contributing to stability. Biochem 20:3096–3102CrossRefGoogle Scholar
  31. Savini L, Gaeta A, Fattorusso C, Catalanotti B, Campiani G, Chiasserini L, Pellerano C, Novellino E, McKissic D, Saxena A (2003) Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. rational design of novel, selective, and highly potent cholinesterase inhibitors. J Med Chem 46:1–4CrossRefPubMedGoogle Scholar
  32. Shaikh SMT, Seetharamappa J, Kandagal PB, Ashoka S (2006) Binding of the bioactive component isothipendyl hydrochloride withovine serum albumin. J Mol Struct 786:46–52CrossRefGoogle Scholar
  33. Tian J, Liu J, He W, Hu Z, Yao X, Chen X (2004) Probing the binding of scutellarin to human serum albumin by circular dichroism, fluorescence spectroscopy, FTIR, and molecular modeling method. Biomacromolecules 5:1956–1961CrossRefPubMedGoogle Scholar
  34. Trinh N, Hoblyn J, Mohanty S, Mohanty S, Yaffe K (2003) Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer Disease: a meta-analysis. J Am Med Assoc 289:210–216CrossRefGoogle Scholar
  35. Tougu V (2001) Acetylcholinesterase: mechanism of catalysis and inhibition. Curr Med Chem 1:155–170Google Scholar
  36. Trynda-Lemiesz L, Karaczyn A, Keppler BK, Kozłowski H (2000) Studies on the interactions between human serum albumin and trans-indazolium (bisindazole) tetrachlororuthenate(III). J Inorg Biochem 78:341–346CrossRefPubMedGoogle Scholar
  37. Wang Q, Jiang H, Chen J, Chen K, Ji R (1998) On the possible reaction pathway for the acylation of AChE-catalyzed hydrolysis of ACh: Semiempirical quantum chemical study. Int J Quantum Chem 70:515–525CrossRefGoogle Scholar
  38. Xiao Q, Huang S, Liu Y, Tian FF, Zhu JC (2009) Thermodynamics, conformation and active sites of the binding of Zn-Nd hetero-bimetallic schiff base to bovine serum albumin. J Fluoresc 19:317–326CrossRefPubMedGoogle Scholar
  39. Xie Y, Yang W, Chen X, Xiao J (2014) Inhibition of flavonoids on acetylcholine esterase: binding and structure–activity relationship. Food Funct 5:2582–2589CrossRefPubMedGoogle Scholar
  40. Zhao XC, Liu RT, Chi ZX, Teng Y, Qin P (2010) New insights into the behavior of bovine serum albumin adsorbed onto carbon nanotubes: comprehensive spectroscopic studies. J Phys Chem B 114:5625–5656CrossRefPubMedGoogle Scholar
  41. Zhang ZJ, Li P, Wang Z, Li PT, Zhang WS, Sun ZH, Zhang XJ, Wang YY (2006) A comparative study on the individual and combined effects of baicalin and jasminoidin on focal cerebral ischemia-reperfusion injury. Brain Res 1123:188–195CrossRefPubMedGoogle Scholar
  42. Zhang W, Zhao Y, Bai X, Hui G, Zhao D, Zhao B (2010) Studies on the Interaction for baicalein and baicalin with human serum albumin by spectroscopic methods. Chem J Chin Univ 31:1834–1840Google Scholar
  43. Zhang DB (2010) The screening of alkaloidal acetylcholinesterase inhibitors from medicinal plan. Master Dissertation, Lanzhou University of TechnologyGoogle Scholar
  44. Zhang LN, Wu FY, Liu AH (2011) Study of the interaction between 2,5-di-[2-(4-hydroxy- phenyl)ethylene]-terephthalonitril and bovine serum albumin by fluorescence spectroscopy. Spectrochim Acta A 79:97–103CrossRefGoogle Scholar
  45. Zhang YZ, Chen XX, Dai J, Liu Y (2008) Spectroscopic studies on the interaction of lanthanum(III) 2-oxo-propionic acid salicyloyl hydrazone complex with bovine serum albumin. J Lumin 23:150–156CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Hebei College of Science and TechnologyBaodingChina
  2. 2.Key Laboratory of Analytical Science and Technology of Hebei ProvinceHebei UniversityBaodingChina

Personalised recommendations